Get research updatesAttention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.
This study evaluates the safety and effectiveness of Methylphenidate Hydrochloride (HCl) Extended Release Chewable Tablet (ERCT) for people with ADHD.
This study was withdrawn before enrollment.
Location not clearly listedA Phase 4, Double-blind, Randomized, Parallel Group, Placebo-controlled Study Of The Efficacy And Safety Of Quillichew (Methylphenidate Hydrochloride (Hcl)) Extended Release Chewable Tablets (Erct) In 4-5 Year Old Children With Attention Deficit Hyperactivity Disorder (Adhd)
This study was withdrawn before enrollment.
Location not clearly listed
A Single-blind Randomised Controlled Trial of Group Cognitive Behavioural Therapy (CBT) Versus Activity Group Control Condition for Adults With Attention Deficit Hyperactivity Disorder (ADHD)
This study has finished and is no longer accepting participants.
In GothenburgSolriamfetol for ADHD in Adults: A Double-Blind Placebo Controlled Pilot Study
This study has finished and is no longer accepting participants.
In Boston
A Genome-wide Association Study on the Endophenotype of Spatial Working Memory in Attention Deficit Hyperactivity Disorder
This study has finished and is no longer accepting participants.
In TaipeiAn Open, Self-Controlled, Prospective Study of Concerta on Cognitive Functions, Efficacy and Tolerance in the Pediatric Patients With Attention Deficit Hyperactivity Disorder (ADHD)
This study has finished and is no longer accepting participants.
Multiple locations, including BeijingMaintenance of Response After Open-Label Treatment With Atomoxetine Hydrochloride in Adult Outpatients With Attention-Deficit/Hyperactivity Disorder (ADHD): A Placebo-Controlled, Randomized Withdrawal Study
This study has finished and is no longer accepting participants.
Multiple locations, including ViennaA Non-interventional Study to Identify Children and Adolescents (Ages 6-17 Years) With Attention Deficit Hyperactivity Disorder and With or Without Copy Number Variants in Specific Genes Involved in Glutamatergic Signaling and Neuronal Connectivity
This study has finished and is no longer accepting participants.
In WayneA Phase II, Two-Stage, Open-Label, Single-Treatment, Adaptive Trial Design Examining the Pharmacokinetic and Pharmacodynamic Effects of up to Three Separate HLD100 Modified Release Formulations of Dextroamphetamine Sulfate in Adolescent (Stage 1) and Pediatric (Stage 2) Patients With Attention-Deficit Hyperactivity Disorder.
This study has finished and is no longer accepting participants.
In SaskatoonResearchers studied Methylphenidate Transdermal System to find out how it affected ADHD symptoms in people with ADHD.
This study has finished and is no longer accepting participants.
In Oklahoma CityA Randomized, Double Blind, Placebo Controlled Study of Homeopathic Treatment of Children and Youth With Attention Deficit Hyperactivity Disorder
This study has finished and is no longer accepting participants.
In TorontoA Randomized Controlled Study of Medical-education-community Collaborated Intervention in Children With Attention Deficit Hyperactivity Disorder
This study was withdrawn before enrollment.
Location not clearly listedWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.